Eisai hopes to create jobs at its UK facility in Hatfield, Hertfordshire, after opening a European Knowledge Centre (EKC) to support the growth of its European, Middle Eastern and African (EMEA) business.
The expansion of its £100 million UK base will improve its geographic reach and increase knowledge interaction across the region.
Gary Hendler, Eisai EMEA President and CEO, said the UK had been chosen due to its “importance as a global hub for the pharmaceutical industry”.
The Hatfield facility opened in 2009 as the Japanese pharma company’s European hub. It currently employs more than 500 people, including 60 research staff and 200 clinical development staff.
The EKC represents one of its biggest ever single capital projects, the company says, and fulfils Eisai’s wish to bring together teams from across its businesses on a single site for the first time and stimulate knowledge.
“Eisai has been successfully operating in Europe for more than 20 years and we are deeply proud to be expanding our efforts to increase access to medicines based on a long-term sustainable strategy to improve affordability, availability and adoption,” said Gary Hendler.
“Our new UK-based EMEA hub will support these efforts, as well as improving knowledge interaction across the region, including shared pricing/reimbursement strategies and the transmission of medical and marketing knowledge.”
The company currently employs more than 11,000 people worldwide and undertakes sales and marketing operations in more than 20 European markets, including the UK, France and Germany.
It is not yet known how many new positions the expansion may create.